SCHEMBL2145267

SCHEMBL2145267

O=C1S/C(=C/c2ccccc2)C=C1Br

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIM1 P11309 3/20 0.44
PIM2 Q9P1W9 3/20 0.44
PIM3 Q86V86 1/20 0.44
CYP1A2 P05177 2/20 0.41
CA2 P00918 1/20 0.41
NAT1 P18440 1/20 0.41
EPHX1 P07099 1/20 0.41
F3 P13726 1/20 0.39
MAOA P21397 4/20 0.39
MAOB P27338 4/20 0.39
MIF P14174 1/20 0.39
ALDH1A1 P00352 4/20 0.38
HPGD P15428 3/20 0.38
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
HTT P42858 1/20 0.38
GAA P10253 1/20 0.38
MAPT P10636 1/20 0.38
ALOX12 P18054 1/20 0.38
MCL1 Q07820 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2145271 1.00 PIM1 (0.44) PIM1PIM2PIM3CYP1A2CA2
SCHEMBL2145265 1.00 PIM1 (0.44) PIM1PIM2PIM3CYP1A2CA2
SCHEMBL10929996 0.73 PIM1 (0.37) PIM1PIM2PIM3CYP1A2CA2
SCHEMBL12204935 0.70 PIM1 (0.49) PIM1PIM2PIM3CA2NAT1
SCHEMBL2145501 0.67 PIM1 (0.44) PIM1PIM2PIM3CYP1A2CA2
SCHEMBL2145506 0.67 PIM1 (0.44) PIM1PIM2PIM3CYP1A2CA2
SCHEMBL2145508 0.67 PIM1 (0.44) PIM1PIM2PIM3CYP1A2CA2
SCHEMBL16628829 0.63 ALDH1A1 (0.50) CYP1A2MAOAMAOBALDH1A1HPGD
SCHEMBL16628828 0.63 ALDH1A1 (0.50) CYP1A2MAOAMAOBALDH1A1HPGD
SCHEMBL2166669 0.63 ALDH1A1 (0.50) CYP1A2MAOAMAOBALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110250254-A1 ANTIMICROBIAL COMPOSITIONS AND USES UNIVERSITETET I OLSO (NO) 2011-10-13 US disclosed
US-20110250254-A1 ANTIMICROBIAL COMPOSITIONS AND USES UNIVERSITETET I OLSO (NO) 2011-10-13 US disclosed
EP-2346330-A1 ANTIMICROBIAL COMPOSITIONS AND USES Universitetet I Oslo (NO) 2011-07-27 EP disclosed
WO-2010040839-A1 ANTIMICROBIAL COMPOSITIONS AND USES UNIVERSITETET I OSLO (NO) 2010-04-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110250254-A1 ANTIMICROBIAL COMPOSITIONS AND USES CBR3, C5, C3AR1 PIM1 1274/4885PIM2 2000/4885PIM3 715/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.